315 related articles for article (PubMed ID: 33494472)
1. Fabrication and Appraisal of Simvastatin via Tailored Niosomal Nanovesicles for Transdermal Delivery Enhancement: In Vitro and In Vivo Assessment.
Salem HF; Kharshoum RM; Abou-Taleb HA; Farouk HO; Zaki RM
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33494472
[TBL] [Abstract][Full Text] [Related]
2. Formulation optimization,
Aldawsari MF; Khafagy ES; Moglad EH; Selim Abu Lila A
Saudi Pharm J; 2023 Sep; 31(9):101734. PubMed ID: 37649675
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
4. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
5. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery.
Akhtar N; Arkvanshi S; Bhattacharya SS; Verma A; Pathak K
J Liposome Res; 2015 Sep; 25(3):191-201. PubMed ID: 25357198
[TBL] [Abstract][Full Text] [Related]
8. Formulation and Evaluation of Azithromycin-Loaded Niosomal Gel: Optimization, In Vitro Studies, Rheological Characterization, and Cytotoxicity Study.
Zaid Alkilani A; Hamed R; Abdo H; Swellmeen L; Basheer HA; Wahdan W; Abu Kwiak AD
ACS Omega; 2022 Nov; 7(44):39782-39793. PubMed ID: 36385887
[TBL] [Abstract][Full Text] [Related]
9. Sustained transdermal delivery of human growth hormone from niosomal gel:
Wang L; Wei L; Long W; Zhang Q; Zou Y
J Biomater Sci Polym Ed; 2022 Jun; 33(9):1198-1212. PubMed ID: 35192434
[TBL] [Abstract][Full Text] [Related]
10. Quality-by-Design-Assisted Optimization of Carvacrol Oil-Loaded Niosomal Gel for Anti-Inflammatory Efficacy by Topical Route.
Ghazwani M; Hani U; Alam A; Alqarni MH
Gels; 2023 May; 9(5):. PubMed ID: 37232993
[TBL] [Abstract][Full Text] [Related]
11. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
Patel KK; Kumar P; Thakkar HP
AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of niosomal gel of fusidic acid: in-vitro and ex-vivo approaches.
Waqas MK; Sadia H; Khan MI; Omer MO; Siddique MI; Qamar S; Zaman M; Butt MH; Mustafa MW; Rasool N
Des Monomers Polym; 2022; 25(1):165-174. PubMed ID: 35711622
[TBL] [Abstract][Full Text] [Related]
13. Qbd-Based Approach to Optimize Niosomal Gel of Levosulpiride for Transdermal Drug Delivery.
Alnaim AS; Shah H; Nair AB; Mewada V; Patel S; Jacob S; Aldhubiab B; Morsy MA; Almuqbil RM; Shinu P; Shah J
Gels; 2023 Mar; 9(3):. PubMed ID: 36975662
[TBL] [Abstract][Full Text] [Related]
14. Optimization of propofol loaded niosomal gel for transdermal delivery.
Zhang W; Zhao X; Yu G; Suo M
J Biomater Sci Polym Ed; 2021 May; 32(7):858-873. PubMed ID: 33538243
[TBL] [Abstract][Full Text] [Related]
15. Development of Niosomal Vesicles Loaded Mometasone Furoate Gel for Transdermal Delivery and its Evaluation.
Rane BR; Chavan PY; Kate NS; Jain AS
Recent Adv Drug Deliv Formul; 2023; 17(4):300-313. PubMed ID: 37974444
[TBL] [Abstract][Full Text] [Related]
16. Etodolac Containing Topical Niosomal Gel: Formulation Development and Evaluation.
Shilakari Asthana G; Asthana A; Singh D; Sharma PK
J Drug Deliv; 2016; 2016():9324567. PubMed ID: 27478643
[TBL] [Abstract][Full Text] [Related]
17. Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.
Aziz DE; Abdelbary AA; Elassasy AI
Curr Drug Deliv; 2018; 15(9):1330-1342. PubMed ID: 29921206
[TBL] [Abstract][Full Text] [Related]
18. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment.
El-Say KM; Abd-Allah FI; Lila AE; Hassan Ael-S; Kassem AE
J Liposome Res; 2016; 26(1):57-68. PubMed ID: 25853339
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of niosomal gel for iontophoresis mediated transdermal delivery of isosorbide dinitrate.
Jain S; Chaudhari BH; Swarnakar NK
Drug Deliv Transl Res; 2011 Aug; 1(4):309-21. PubMed ID: 25788365
[TBL] [Abstract][Full Text] [Related]
20. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
